Skip to main content

Antimicrobial resistance of Shigella spp. in South Australia and its detection using WGS

In brief

Whole-genome sequencing missed ampicillin resistance in 17 Shigella isolates

In a five-year South Australian review, whole-genome sequencing results agreed with laboratory resistance tests 96% of the time overall, but missed resistance in 17 ampicillin-resistant isolates. Detection varied by drug, and sequencing also flagged resistance in some susceptible isolates. These errors show why each organism-drug combination needs local validation before sequencing is used for resistance surveillance.

Journal
The Journal of antimicrobial chemotherapy (Q1)
Published
3 November 2026
Study design
Cohort / observational study
Evidence level
Level 3, Low (CEBM 3b)
Authors
Helena Torpy, Arshdeep Kaur Mudhar, Lex E X Leong, Casey Moore, Helen Hocking, Emily Rowe, et al.
PMID
43021629
DOI
10.1093/jac/dkag343

Why clinicians should know about it

  • Picked for Microbiology (medical) (top studies of the week, 15 November 2026): Compares WGS-derived resistance predictions with phenotypic susceptibility testing

Abstract

BACKGROUND: The use of WGS for antimicrobial susceptibility testing (AST) is limited by incomplete understanding of the correlation of genetic variants with phenotypic antimicrobial resistance (AMR). OBJECTIVES: A 5 year retrospective review of Shigella isolates in South Australia was undertaken to compare the results of phenotypic AST with WGS-derived AMR to determine the ability of WGS to infer phenotypic resistance. METHODS: Pure colonies from confirmed Shigella isolates were selected and DNA extracted using the automated QIASymphony platform. Isolates were sequenced using an Illumina NextSeq platform. The Comprehensive Antibiotic Resistance Database (CARD) was used with the AMR screening tool 'ABRicate' to screen assemblies for the presence of intrinsic AMR genes. In addition, the AMRFinderPlus tool with NCBI's compiled database National Database of Antibiotic-Resistant Organisms (NDARO) was used to detect resistance-conferring point mutations, and to verify intrinsic AMR gene screening. The WGS and phenotypic AST results were compared. RESULTS: There was 96% correlation between phenotypic and WGS-AST. The sensitivity of WGS-AST for prediction of AMR varied according to the antimicrobial: ceftriaxone (100%), azithromycin (100%), ciprofloxacin (100%), ampicillin (88.7%) and trimethoprim/sulfamethoxazole (93.5%). WGS failed to detect resistance in 17 ampicillin-resistant isolates, constituting very major errors. False-positive results included the detection of AmpC blaCMY59 in four ceftriaxone-susceptible Shigella flexneri isolates and genotypic ciprofloxacin resistance in two phenotypically susceptible isolates: one carrying qnrS1 and one carrying four quinolone resistance-determining region point mutations. CONCLUSIONS: The unexpectedly high rate of false-negative WGS-AST results for detection of ampicillin and trimethoprim/sulfamethoxazole resistance highlights the importance of local validation studies of WGS-AST for specific organism-antimicrobial combinations prior to its use in AMR surveillance.

Abstract as published, via PubMed.

View on PubMedFull text at the publisherOpen in the app

For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.